Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Thursday, May 7, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
People on the Move
AI Proteins Names James Bowman as First Chief Technology Officer
Life Sciences Times
-
August 26, 2025
0
Healthcare
Carna Health and Siemens Healthineers Sign Agreement to Expand AI-Powered Kidney Care
Life Sciences Times
-
August 26, 2025
0
Venture Capital
Generational Group Advises Lockwood Manufacturing on Sale to Brattle Technologies
Life Sciences Times
-
August 26, 2025
0
People on the Move
Insulet Names Eric Benjamin Chief Operating Officer; Manoj Raghunandanan Appointed Chief Growth Officer
Life Sciences Times
-
August 26, 2025
0
Healthcare
Iterative Health and One GI Partner to Expand Clinical Research in Gastroenterology
Life Sciences Times
-
August 26, 2025
0
Life Sciences
India’s Hyderabad Among World’s Top Seven Life Sciences Clusters
Life Sciences Times
-
August 26, 2025
0
Venture Capital
ProVerum Raises $80 Million in Series B to Advance Commercialization of BPH Treatment
Life Sciences Times
-
August 25, 2025
0
Pharma
Cambrex Expands Peptide Manufacturing Capabilities at Waltham, Massachusetts Facility
Life Sciences Times
-
August 25, 2025
0
Pharma
Merz Therapeutics Begins Phase III Trials of XEOMIN® for Migraine Prevention
Life Sciences Times
-
August 25, 2025
0
People on the Move
Sonoma Biotherapeutics Appoints Lisa Taylor Ash as Chief Legal Officer
Life Sciences Times
-
August 25, 2025
0
1
...
125
126
127
...
835
Page 126 of 835
Most Popular
Museum of Science Raises Record $1.8 Million at Stars of STEM Gala
May 7, 2026
enGene Reports Updated Interim Results From Bladder Cancer Trial
May 7, 2026
Elucid’s Plaque-IQ Wins MedTech Breakthrough Cardiology Technology Award
May 7, 2026
Scholar Rock Reports First-Quarter Results as FDA Review of Apitegromab Advances
May 7, 2026
Load more
Recent Comments
Recent Comments